Literature DB >> 9179202

Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer.

O Schillaci1, F Scopinaro, R Danieli, R Tavolaro, P Cannas, V Picardi, A C Colella.   

Abstract

BACKGROUND: The status of the axillary lymph nodes is the most important prognostic factor in breast cancer, and the findings of axillary node dissection remain the gold standard for the patients staging and prognosis. The aim of this study was to evaluate the usefulness of Tc-99m sestamibi scintigraphy in the detection of axillary node involvement.
MATERIALS AND METHODS: Forty-nine patients (age range: 32-72 years) with breast cancer were studied. Dynamic images (1-20 minutes post-injection of the radiopharmaceutical) followed by multiple planar views and tomographic images were performed. Final diagnosis was achieved by histology after surgery.
RESULTS: Metastatic axillary lymph node involvement was present in 21 patients: sensitivity was 81% (17/21) for tomographic and 61.9% (13/21) for planar images; specificity was 92.9% (26/28) and 96.4% (27/28), respectively.
CONCLUSIONS: Tc-99m sestamibi imaging is a promising noninvasive method to detect axillary node metastases in patients with breast cancer, tomography appears more sensitive than planar views.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179202

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.

Authors:  Giuseppe Madeddu; Angela Spanu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-15       Impact factor: 9.236

2.  Planar Tc99m--sestamibi scintimammography should be considered cautiously in the axillary evaluation of breast cancer protocols: results of an international multicenter trial.

Authors:  Teresa Massardo; Omar Alonso; Augusto Llamas-Ollier; Levin Kabasakal; Uma Ravishankar; Rossana Morales; Lucía Delgado; Ajit K Padhy
Journal:  BMC Nucl Med       Date:  2005-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.